PRISCILLA COONEY: Open Payments
NPI 1649401902 · KINGSTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,372 in 113 payments from 37 companies in 2025. Trend: 2023 $2,689 · 2024 $2,078 · 2025 $2,372
Food & beverage: $2,372
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $262 |
| PFIZER INC. | 15 | $252 |
| Genentech USA, Inc. | 7 | $173 |
| Daiichi Sankyo Inc. | 8 | $139 |
| Novartis Pharmaceuticals Corporation | 6 | $134 |
| ABBVIE INC. | 5 | $111 |
| E.R. Squibb & Sons, L.L.C. | 5 | $101 |
| GlaxoSmithKline, LLC. | 4 | $90 |
| Janssen Biotech, Inc. | 3 | $76 |
| ARRAY BIOPHARMA INC | 3 | $68 |
Products named: Enhertu, IBRANCE, ELREXFIO, CALQUENCE, OPDIVO, OJJAARA, INJECTAFER, VERZENIO.
Industry payments across PA — which companies pay providers there.
